MedTrace Logo

LYNG21: Ably LYNG Clinical Demonstration in Operative Environment

NCT05117606 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-11-11

No results posted yet for this study

Summary

The study main objective will be to compare measurements of heart rate, respiration rate, blood pressure and movement done by LYNG by Ably Medical with the corresponding measurements made by standard equipment in a patient sample in a hospital setting. The comparison will show the degree of agreement between LYNG and the existing current standard equipment. Data from the study will support Ably Medical in optimizing the LYNG product and measurement precision.

Conditions

  • Monitoring, Physiologic

Interventions

DEVICE

LYNG by Ably Medical

Comparing LYNG to traditional, standard equipment for heart rate, respiration, movement, and blood pressure.

Sponsors & Collaborators

  • Alesund Hospital

    collaborator OTHER

  • Ably Medical AS

    lead INDUSTRY

Principal Investigators

  • Dag A Lihaug Hoff · HMR Aalesund Hospital

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-25
Primary Completion
2021-12-01
Completion
2021-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05117606 on ClinicalTrials.gov